Cargando…
Recent Advances in Models, Mechanisms, Biomarkers, and Interventions in Cisplatin-Induced Acute Kidney Injury
Cisplatin is a widely used chemotherapeutic agent used to treat solid tumours, such as ovarian, head and neck, and testicular germ cell. A known complication of cisplatin administration is acute kidney injury (AKI). The development of effective tumour interventions with reduced nephrotoxicity relies...
Autores principales: | Holditch, Sara J., Brown, Carolyn N., Lombardi, Andrew M., Nguyen, Khoa N., Edelstein, Charles L. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627318/ https://www.ncbi.nlm.nih.gov/pubmed/31226747 http://dx.doi.org/10.3390/ijms20123011 |
Ejemplares similares
-
Pathophysiology of Cisplatin-Induced Acute Kidney Injury
por: Ozkok, Abdullah, et al.
Publicado: (2014) -
Biomarkers of Acute Kidney Injury
por: Sirota, Jeffrey C., et al.
Publicado: (2011) -
Surgical procedures suppress autophagic flux in the kidney
por: Brown, Carolyn N., et al.
Publicado: (2021) -
Mediators of Inflammation in Acute Kidney Injury
por: Akcay, Ali, et al.
Publicado: (2009) -
Autophagy and necroptosis in cisplatin-induced acute kidney injury: Recent advances regarding their role and therapeutic potential
por: Alassaf, Noha, et al.
Publicado: (2023)